India Pharma Outlook Team | Tuesday, 29 September 2026
Andhra Pradesh’s cancer cases are projected to reach 64,990 among adults in 2026, according to the “Cancer Burden Profile 2026: Andhra Pradesh” released by ICMR-NINE under the National Cancer Registry Program.
The estimate comprises 35,646 cases among women and 29,344 among men.
While the headline figure points to the scale of the cancer burden, the report also highlights a less-noticed issue: limited participation in cancer screening.
This creates a wider challenge for Andhra Pradesh, where the health system is expanding screening and treatment capacity even as the latest data points to gaps in early detection.
The distribution of cancer cases in Andhra Pradesh differs significantly between men and women. Among men, oral cavity cancer is projected to account for 15.3 percent or 4,498 cases, followed by lung cancer at 9.7 percent or 2,852 cases.
Colorectal, prostate and stomach cancers account for another 8.8 percent, 6.9 percent and 6.2 percent, respectively. Together, these five represent nearly 47 percent of the estimated male cancer burden.
For women, breast cancer is the largest contributor, accounting for 27.9 percent or 9,941 cases. Cervical cancer follows at 12.7 percent or 4,540 cases, while colorectal, corpus uteri and ovarian cancers account for 6 percent, 5.9 percent and 5.3 percent, respectively.
These five together represent nearly 58 percent of estimated cases among women.
Also Read: Why Peptides and Complex Generics Will Define India Pharma's Future
Andhra Pradesh’s cancer burden becomes more significant when considered alongside screening participation.
ICMR-NINE reports that among women aged 30–49, only 4.7 percent have ever undergone cervical cancer screening, while 0.8 percent have undergone a breast examination and 7.3 percent an oral-cavity examination.
Among men in the same age group, only 6.3 percent have undergone an oral-cavity examination. This gap is particularly relevant because the state is already conducting large-scale non-communicable disease screening.
As of August 31, 2026, Andhra Pradesh's NCD 4.0 program had screened 2.82 crore people aged 18 and above, covering 66.05 percent of its target population. The program had also confirmed 2,026 oral cancer, 3,571 breast cancer and 2,076 cervical cancer cases following clinical evaluation of suspected cases.
Tobacco remains an important factor in the state's cancer profile. ICMR-NINE reports current tobacco use among people aged 15 and above at 22.6 percent among men and 3.8 percent among women.
Alcohol use is reported at 23.3 percent among men and 0.5 percent among women.
Overweight and obesity affect 31.1 percent of men and 36.3 percent of women aged 15–49, while hypertension affects 29 percent of men and 25.3 percent of women aged 15 and above.
These indicators place cancer within a broader public-health challenge involving lifestyle-related and chronic diseases.
The state's response is increasingly focused on both screening and treatment infrastructure. Andhra Pradesh currently has one population-based cancer registry and 12 hospital-based cancer registries, according to the ICMR-NINE profile.
The latest findings therefore highlight a two-sided requirement: expanding specialized cancer treatment while improving participation in early detection programs.
In February 2026, the Andhra Pradesh government said more than Rs 4,751 crore had been spent through NTR Vaidya Seva Trust on free cancer treatment for over 6.32 lakh patients since 2007.
It also announced pain and palliative Care Units at teaching hospitals in Kurnool, Guntur, Kakinada, Visakhapatnam and Tirupati, with plans to extend such facilities to more hospitals and district centers. Visakhapatnam is emerging as an important specialized-care hub.
Union government has been expanding decentralized cancer services through Day Care Cancer Centers, while new Critical Care Blocks have also been inaugurated across districts including Visakhapatnam, Kurnool, Nellore, Kadapa and Vijayawada.
Andhra Pradesh is adding treatment capacity, but the ICMR-NINE profile shows that early detection and screening participation remain important gaps. Closing that gap could determine how effectively the state's growing cancer-care infrastructure translates into earlier diagnosis and timely treatment.